ArticleBone marrow transplantation2026
Results of brexucabtagene-autoleucel for patients with relapsed/refractory Mantle Cell Lymphoma in the routine setting in Germany and Switzerland.
Linda Simon et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.